Search
EPA Compliance Audit Guidance: New Owner, Voluntary Disclosure, Admission of Liability, Penalty Mitigation The CLE course will address the EPA's most recent guidance for environmental counsel related to its audit policy. The panel will provide an overview of the EPA's incentives to companies that...
"What happens to a band name when a band breaks up? In the case of The Guess Who, there was no agreement between the band members on use, so original bassist Jim Kale registered THE GUESS WHO as a trademark in the United States in 1986 without telling the other band members."
On November 15, 2023, Matt Kohel will be speaking at the Maryland State Bar Association Business Law & Technology: What Transactional Lawyers Need to Know About AI and Cybersecurity event, as part of MSBA Legal Excellence Week. Matt's topic on which he will be speaking is "Cybersecurity, Data...
In an age where technology permeates nearly every facet of business, the importance of having a general understanding of Information Technology (IT) contracts is crucial.
Matthew Kohel, a partner in Saul Ewing's Litigation Department, hosted a webinar discussing the implementation of best practices and responsible use policies to manage the risk of utilizing AI in the workplace. The presentation focused on the identification and management of risks that can arise...
Andrew Bockis will discuss "What Lawyers Should Know About Hydrogen Hubs" at the Pennsylvania Bar Institute's Oil & Gas Law Conference 2023. This conference explores recent legislative and case law developments as well as technological advancements in the oil and gas industry. In addition to being a...
John Dixon moderated a panel on “New Challenges and Opportunities in Environmental Permitting” during the Pennsylvania Bar Institute’s 2023 Oil and Gas Law Conference. Also on the panel were attorneys from the Pennsylvania Department of Environmental Protection and Citizens for Pennsylvania’s Future...
Athira Sivan (Philadelphia) and Bill Warren (Harrisburg) presented on “The Non-Profit Legal Lifecycle: Legal Requirements for New CWOs From Formation to Operation” at the 2023 Pennsylvania Statewide Conference for Watershed Organizations on October 30, 2023. Their appearance before the group of...
In September, the Consumer Financial Protection Bureau issued guidance on compliance with the Equal Credit Opportunity Act’s adverse action notice requirements for lenders utilizing artificial intelligence in their credit decision process. Specifically, the Bureau noted that lenders may not rely...
This issue of Saul on ESG: Trends & Updates marks our first update tracking the legal trends and developments around environmental, social and governance (ESG). In recent years, we have been tracking and highlighting changes on the ESG front, but this regular publication will allow us to dive...
Matt Kohel will participate as speaker during the Responsible AI in Intelligence Analysis conference at Georgetown University in Washington, D.C. Matt will speak on a panel titled AI Governance, Privacy and Civil Liberties Compliance.
Developing a Corporate AI Policy Join Association of Corporate Counsel, along with inside and outside counsel presenters, as they discuss implementing best practices and responsible use policies to manage the risk of utilizing AI in the workplace. Speakers: Matthew Kohel, Partner, Intellectual...
Since Elon Musk announced his decision to remove the iconic bird logo and adopt "X", as Twitter's new logo (the "X Logo"), the rebranding decision has been the talk of the town. The rollout has prompted a barrage of reactions and has many questioning whether the change will attract legal hurdles...
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the second quarter of 2023. If you would like to discuss...
On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...